KINTARO Okinawa

Kintaro Cells Power is a biotechnology company specializing in regenerative medicine through the development and application of bone marrow-derived Mesenchymal Stem Cells (MSCs). Headquartered in Tokyo with its primary manufacturing and research facility in Okinawa, the company utilizes a proprietary cell culture technology to produce high-purity "Kintaro Cells." These cells are utilized globally for a wide range of therapeutic applications, including the treatment of diabetes, cardiovascular conditions, and age-related degeneration. The company operates a robust network of partner clinics and research institutions, providing cell-based products and clinical services across Japan, Southeast Asia, and the Middle East. Kintaro Cells Power is recognized for its GMP-compliant manufacturing processes and its focus on non-invasive, autologous and allogeneic stem cell solutions.